Cerus Corporation (NASDAQ: CERS) is a Healthcare company (Medical - Devices) with a market capitalization of $384M. The Maz Rating grades it against the other companies in its sector.
Cerus Corporation's current Maz Rating and its five factor grades are for members: log in to see them.
At $1.90, Cerus Corporation trades at 1.7x sales and 5.0x book value. Over the last twelve months it generated about $231M of revenue and a net loss of $8M. It runs a gross margin of 51.8%, an operating margin of -3.9% and a net margin of -3.2%. It shows return on equity of -10.5%, return on invested capital of -5.6% and a free cash flow yield of 0.1%. On the balance sheet: a debt-to-equity ratio of 0.99 and a current ratio of 1.96. Over the past 52 weeks the share price ranged from $1.47 to $3.47, with a beta of 1.85.
Cerus Corporation does not currently pay a dividend.
10 Wall Street analyst ratings cover the stock: 8 Buy and 2 Hold, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.